版本:
中国

BRIEF-Galenica appoints new CFO, new management at Vifor Pharma

Oct 6 Galenica AG :

* New management at Vifor Pharma and new Galenica Group CFO designated

* Stefan Schulze will take over this position from the annual general meeting of Galenica Ltd. in May 2017

* From that date, Felix Burkhard will take over as CFO from Joerg Kneubuehler

* Kneubuehler will in future concentrate fully on his role as CEO of Galenica Santé

* Has designated Stefan Schulze, currently CEO of Vifor Fresenius Medical Care Renal Pharma (VFMCRP), as chief operating officer (COO) and president of executive committee of Vifor Pharma

* The board of directors has also appointed Felix Burkhard as CFO of the Galenica Group with effect from January 1, 2017

* Previous guidance in respect of 2016 Galenica Group net profit increasing by approximately 10 percent before and after deduction of minority interests on a comparable basis is confirmed

* Guidance in respect of 2016 Galenica Group net profit decreasing by approximately 90 million Swiss francs ($92.31 million) as a result of the investment required to ramp-up sales of Veltassa is unchanged Source text - bit.ly/2dujKKr Further company coverage: ($1 = 0.9750 Swiss francs) (Gdynia Newsroom)

更多 瑞士市场报道

热门文章

编辑推荐

文章推荐